Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade.
Jeong S, Park E, Kim HD, Sung E, Kim H, Jeon J, Kim Y, Jung UJ, Son YG, Hong Y, Lee H, Lee S, Lim Y, Won J, Jeon M, Hwang S, Fang L, Jiang W, Wang Z, Shin EC, Park SH, Jung J. Jeong S, et al. Among authors: hwang s. J Immunother Cancer. 2021 Jul;9(7):e002428. doi: 10.1136/jitc-2021-002428. J Immunother Cancer. 2021. PMID: 34230109 Free PMC article.
Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis A.
Kim J, Chang DY, Lee HW, Lee H, Kim JH, Sung PS, Kim KH, Hong SH, Kang W, Lee J, Shin SY, Yu HT, You S, Choi YS, Oh I, Lee DH, Lee DH, Jung MK, Suh KS, Hwang S, Kim W, Park SH, Kim HJ, Shin EC. Kim J, et al. Among authors: hwang s. Immunity. 2018 Jan 16;48(1):161-173.e5. doi: 10.1016/j.immuni.2017.11.025. Epub 2018 Jan 2. Immunity. 2018. PMID: 29305140 Free article.
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer.
Kim BS, Kuen DS, Koh CH, Kim HD, Chang SH, Kim S, Jeon YK, Park YJ, Choi G, Kim J, Kang KW, Kim HY, Kang SJ, Hwang S, Shin EC, Kang CY, Dong C, Chung Y. Kim BS, et al. Among authors: hwang s. J Immunother Cancer. 2021 Jun;9(6):e002603. doi: 10.1136/jitc-2021-002603. J Immunother Cancer. 2021. PMID: 34083422 Free PMC article.
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response.
Kang J, Jeong JH, Hwang HS, Lee SS, Park DH, Oh DW, Song TJ, Kim KH, Hwang S, Hwang DW, Kim SC, Park JH, Hong SM, Kim KP, Ryoo BY, Yoo C. Kang J, et al. Among authors: hwang hs, hwang dw, hwang s. Cancer Res Treat. 2020 Apr;52(2):594-603. doi: 10.4143/crt.2019.493. Epub 2019 Dec 18. Cancer Res Treat. 2020. PMID: 32019287 Free PMC article.
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation.
Bang K, Casadei-Gardini A, Yoo C, Iavarone M, Ryu MH, Park SR, Kim HD, Yoon YI, Jung DH, Park GC, Ahn CS, Moon DB, Hwang S, Kim KH, Song GW, Mazzarelli C, Alimenti E, Chan SL, De Giorgio M, Ryoo BY, Lee SG. Bang K, et al. Among authors: hwang s. Cancer Med. 2023 Feb;12(3):2572-2579. doi: 10.1002/cam4.5123. Epub 2022 Aug 5. Cancer Med. 2023. PMID: 36812124 Free PMC article.
12,714 results
You have reached the last available page of results. Please see the User Guide for more information.